| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.
|
Eur J Immunol
|
1981
|
4.31
|
|
2
|
Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation.
|
Blood
|
1994
|
2.16
|
|
3
|
Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
|
N Engl J Med
|
1992
|
1.59
|
|
4
|
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.
|
J Clin Oncol
|
1997
|
1.57
|
|
5
|
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia.
|
Ann Hematol
|
1994
|
1.51
|
|
6
|
Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation.
|
Bone Marrow Transplant
|
1998
|
1.43
|
|
7
|
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
|
Cancer
|
2001
|
1.30
|
|
8
|
Initial results in the assessment of multiple myeloma using 18F-FDG PET.
|
Eur J Nucl Med Mol Imaging
|
2002
|
1.28
|
|
9
|
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia.
|
Leukemia
|
2011
|
1.24
|
|
10
|
Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.
|
Br J Haematol
|
2000
|
1.20
|
|
11
|
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia.
|
J Clin Oncol
|
2002
|
1.15
|
|
12
|
Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling.
|
J Cell Mol Med
|
2008
|
1.15
|
|
13
|
Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant.
|
J Clin Oncol
|
1994
|
1.14
|
|
14
|
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
|
Leukemia
|
2008
|
1.13
|
|
15
|
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma.
|
Blood
|
1995
|
1.09
|
|
16
|
Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: results of a prospective study.
|
J Psychosom Res
|
2001
|
1.07
|
|
17
|
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
|
Bone Marrow Transplant
|
1995
|
1.06
|
|
18
|
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
|
Blood
|
1998
|
0.98
|
|
19
|
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.
|
Lancet
|
2000
|
0.97
|
|
20
|
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.
|
Leukemia
|
2006
|
0.94
|
|
21
|
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study.
|
Ann Hematol
|
2001
|
0.92
|
|
22
|
Radioimmunoconjugates in acute leukemia treatment: the future is radiant.
|
Bone Marrow Transplant
|
2005
|
0.91
|
|
23
|
CMV monitoring using blood cells and plasma: a comparison of apples with oranges?
|
Bone Marrow Transplant
|
2007
|
0.89
|
|
24
|
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.
|
J Intern Med
|
2012
|
0.86
|
|
25
|
Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.
|
Bone Marrow Transplant
|
2003
|
0.86
|
|
26
|
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome.
|
Bone Marrow Transplant
|
2000
|
0.85
|
|
27
|
Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography.
|
J Eur Acad Dermatol Venereol
|
2003
|
0.85
|
|
28
|
Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors.
|
Transplantation
|
1984
|
0.83
|
|
29
|
Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts.
|
Transplantation
|
1987
|
0.83
|
|
30
|
CAMPATH-1 antibodies in stem-cell transplantation.
|
Cytotherapy
|
2001
|
0.82
|
|
31
|
Psychological distress of patients undergoing intensified conditioning with radioimmunotherapy prior to allogeneic stem cell transplantation.
|
Bone Marrow Transplant
|
2005
|
0.82
|
|
32
|
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
|
Bone Marrow Transplant
|
2000
|
0.82
|
|
33
|
Frequency, specificity, and phenotype of clonally growing human alloreactive interleukin-2-secreting helper T lymphocyte precursors.
|
Transplantation
|
1990
|
0.82
|
|
34
|
Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.
|
Eur J Nucl Med
|
1999
|
0.81
|
|
35
|
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
|
J Nucl Med
|
2000
|
0.80
|
|
36
|
Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells.
|
Bone Marrow Transplant
|
1993
|
0.80
|
|
37
|
Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
|
Transplantation
|
1993
|
0.79
|
|
38
|
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
|
Ann Hematol
|
2001
|
0.79
|
|
39
|
Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1996
|
0.79
|
|
40
|
Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563).
|
Transplant Proc
|
1994
|
0.79
|
|
41
|
Measurement of recipient-specific alloreactivity: is GVHD predictable?
|
Bone Marrow Transplant
|
1993
|
0.79
|
|
42
|
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
|
Br J Haematol
|
1986
|
0.78
|
|
43
|
Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.
|
Infection
|
1989
|
0.78
|
|
44
|
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells.
|
Bone Marrow Transplant
|
1997
|
0.78
|
|
45
|
In vitro and in vivo depletion of T cells.
|
Bone Marrow Transplant
|
1993
|
0.78
|
|
46
|
Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation.
|
Blood
|
1993
|
0.78
|
|
47
|
Severe Chlamydia pneumoniae infection in patients with neutropenia: case reports and literature review.
|
Clin Infect Dis
|
2000
|
0.78
|
|
48
|
Pretransplant detection of human minor histocompatibility antigen-specific naive and memory interleukin-2-secreting T cells within class I major histocompatibility complex (MHC)-restricted CD8+ and class II MHC-restricted CD4+ T-cell subsets.
|
Blood
|
1993
|
0.78
|
|
49
|
High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1994
|
0.78
|
|
50
|
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation.
|
Scand J Infect Dis
|
1988
|
0.78
|
|
51
|
Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma.
|
Bone Marrow Transplant
|
2012
|
0.78
|
|
52
|
Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.
|
Br J Haematol
|
1999
|
0.77
|
|
53
|
Pathophysiological aspects of predominant preload lowering on pulmonary circulation, gas exchange, and the biventricular function in patients with chronic obstructive lung disease.
|
Clin Cardiol
|
1988
|
0.77
|
|
54
|
Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.
|
Klin Wochenschr
|
1987
|
0.76
|
|
55
|
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation.
|
Eur J Nucl Med
|
2001
|
0.76
|
|
56
|
T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia.
|
Eur J Haematol
|
1988
|
0.76
|
|
57
|
ABO-incompatible bone marrow transplantation.
|
Beitr Infusionsther
|
1992
|
0.76
|
|
58
|
Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation.
|
Leukemia
|
1993
|
0.75
|
|
59
|
Cyclosporine as an alternative to cyclophosphamide in the treatment of chronic graft-versus-host disease.
|
Transplantation
|
1986
|
0.75
|
|
60
|
[Bone marrow transplantation as therapy in chronic myeloid leukemia].
|
Dtsch Med Wochenschr
|
1988
|
0.75
|
|
61
|
Kinetics of relapse of leukemia after bone marrow transplantation: cytogenetic follow up of patients with chronic myelogenous leukemia.
|
Bone Marrow Transplant
|
1991
|
0.75
|
|
62
|
Relation of noninvasive parameters and pulmonary artery mean pressure in patients with chronic obstructive lung disease.
|
Clin Physiol Biochem
|
1988
|
0.75
|
|
63
|
Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease.
|
Bone Marrow Transplant
|
2001
|
0.75
|
|
64
|
[Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
|
Beitr Infusionsther Transfusionsmed
|
1994
|
0.75
|
|
65
|
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.
|
Bone Marrow Transplant
|
1998
|
0.75
|
|
66
|
[Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation. No increase of proinflammatory cytokine levels of TNF-alpha].
|
Nuklearmedizin
|
2009
|
0.75
|
|
67
|
Graft rejection after syngeneic bone marrow transplantation for aplastic anaemia: significance of coculture studies.
|
Br J Haematol
|
1985
|
0.75
|
|
68
|
CD 54 expression and its role in homotypic aggregation of the blasts of acute myeloblastic leukemias (AML).
|
Int J Hematol
|
1994
|
0.75
|
|
69
|
Neurological outcome after a severe herpes simplex encephalitis treated with acyclovir and beta-interferon. Time course of intracranial pressure.
|
Klin Wochenschr
|
1990
|
0.75
|
|
70
|
Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMT.
|
Br J Haematol
|
1998
|
0.75
|
|
71
|
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
|
Blood
|
2000
|
0.75
|
|
72
|
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patients.
|
Eur J Haematol
|
1998
|
0.75
|
|
73
|
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.
|
Ann Hematol
|
1998
|
0.75
|
|
74
|
Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse.
|
J Hematother
|
1999
|
0.75
|
|
75
|
Treatment results of nine patients with Burkitt's lymphoma.
|
Blut
|
1986
|
0.75
|
|
76
|
Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation.
|
Bone Marrow Transplant
|
2012
|
0.75
|
|
77
|
Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
|
Genes Chromosomes Cancer
|
2001
|
0.75
|
|
78
|
Comparative analysis of in vivo T cell depletion with radiotherapy, combination chemotherapy, and the monoclonal antibody Campath-1G, using limiting dilution methodology.
|
Transplantation
|
1990
|
0.75
|
|
79
|
Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.
|
Nuklearmedizin
|
2006
|
0.75
|